Breaking News

Scientists discover compound that targets cancer cells

Developed and tested at the University of Huddersfield, the compound, containing ruthenium, is attracted to vulnerable ...

Limits of drug repurposing

A new study at Cambridge Judge Business School demonstrates how rare it is to find entirely new uses for existing ...

Getting a good gut feeling

In the near future, doctors may be able to diagnose and treat patients’ physical and mental health problems by ...

In vivo models to target respiratory diseases

Envigo’s Steve Jordan offers intuitive analysis and insights into methods of optimising in vivo efficacy studies and ...

Almac Discovery, Elasmogen and Innovate UK collaborate

The £2 million collaborative project will aim to build a versatile platform to facilitate the discovery and development ...

DotBio launches focusing on immuno-oncology drugs

Newly formed company raises $2.3 million seed financing to complete validation studies of optimised, humanised domain ...

The nanozyme that uses light to kill bacteria

Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge ...

The MERIT of working with microalgae

Algenuity is celebrating the successful launch of the MicroalgaE as Renewable Innovative green cell facTories project, ...

CrownBio expands humanised models for targeted immunotherapy

The humanised model expansion programme will begin with PD-1, CTLA-4 and CD137 models

Miniaturised organ equivalents for drug testing

Dr Reyk Horland, VP Business Development of TissUse, speaks to Angharad Baldwin of Manufacturing Chemist about a ...

Accelerating drug discovery

Angharad Baldwin of Manufacturing Chemist speaks to Dr Trevor Perrior, CSO of Domainex, about the development of a new ...

Global partnership to expand pharma biocatalysis uptake

Codexis, Inc. and Porton Pharma Solutions recently announced a strategic collaboration to deploy Codexis’ world-leading ...

Grant awarded to doctors researching innovative PDX models in immuno-oncology

Crown Bioscience awarded Dr Lavial and his colleagues the grant due to their project's potential to create b ...

Robot chemist discovers new molecules and reactions

A new type of artificial-intelligence-driven chemistry could revolutionise the way molecules are discovered, scientists ...